Recent studies have shown that the aberrant expression level of CIP2A/p90 is either significantly correlated with tumor stages or serves as a prognostic marker for overall survival (OS) and disease-free survival (DFS) (Table 2). This evidence concerns the gene CIP2A and neoplasm.